Literature DB >> 6143559

In vitro interactions of agonists and antagonists with beta-adrenergic receptors.

S N Abramson, P B Molinoff.   

Abstract

Neurotransmitters and hormones mediate their effects through interaction with specific receptors. A complete understanding of the effects of these chemical signals requires detailed knowledge, at the molecular level, of agonist/receptor interactions. It is likely that agonists and antagonists interact with the same site on a receptor. Agonists, however, are by definition different from antagonists in that agonists are responsible for transducing information across the cell membrane, ultimately resulting in a biological response, while antagonists appear to act through passive occupancy of receptors. Implicit in this concept is the idea that these fundamental differences between agonists and antagonists arise from the sequelae induced by agonist-specific interactions with receptors.

Mesh:

Substances:

Year:  1984        PMID: 6143559     DOI: 10.1016/0006-2952(84)90440-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Regulation of membrane histamine H1-receptor binding sites by guanine nucleotides, mono- and divalent cations.

Authors:  M Carman-Krzan
Journal:  Agents Actions       Date:  1986-04

2.  Characterization of vascular histamine H1-receptors: multiple affinity states of aortic histamine H1-receptor.

Authors:  M Carman-Krzan
Journal:  Agents Actions       Date:  1985-04

3.  Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.

Authors:  A T Nials; M J Sumner; M Johnson; R A Coleman
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

4.  Roles of Ca2+ in human neutrophil responses to receptor agonists.

Authors:  J T O'Flaherty; A G Rossi; D P Jacobson; J F Redman
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

5.  GTP-independent stimulation of rabbit heart adenylate cyclase by isoproterenol at physiological ATP concentrations.

Authors:  S E Harding; A M Hopwood; P Harris
Journal:  Basic Res Cardiol       Date:  1989 Jan-Feb       Impact factor: 17.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.